EUVIMEDEUVIMED entdecken
Crossref

Small Molecules as Anti‐inflammatory Agents: Molecular Mechanisms and Heterocycles as Inhibitors of Signaling Pathways

N. Jeelan Basha

ChemistrySelect · 06.03.2023 · 8 (9)

DOI: 10.1002/slct.202204723 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemistrySelect, online erschienen am 02.03.2023. Verfasst von N. Jeelan Basha. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 163 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer and inflammation interlink with many pathways. Millions of people died because of these two disorders. Major pathways that cause both inflammation and cancer are STAT3, NF‐κB, COX, and histone acetylation. However, these are the target for medicinally potent heterocycles such as pyrimidines, indole, and pyrazole. Many NSAIDs reported in the literature belong to both natural and synthetic molecules. This review encompasses molecular mechanisms for inflammation, NSAIDs derived from natural sources and synthetic methods, and recent reports on heterocycles as potent anti‐inflammatory agents and their significance in cancer treatment. Literature for the study, accomplished from 2019 to 2022.

Zitieren

APA

Basha, N. J. (2023). Small Molecules as Anti‐inflammatory Agents: Molecular Mechanisms and Heterocycles as Inhibitors of Signaling Pathways. ChemistrySelect, 8(9). https://doi.org/10.1002/slct.202204723

Vancouver

Basha NJ. Small Molecules as Anti‐inflammatory Agents: Molecular Mechanisms and Heterocycles as Inhibitors of Signaling Pathways. ChemistrySelect. 2023;8(9). doi:10.1002/slct.202204723

BibTeX
@article{Basha2023,
  author = {Basha, N. Jeelan},
  title = {Small Molecules as Anti‐inflammatory Agents: Molecular Mechanisms and Heterocycles as Inhibitors of Signaling Pathways},
  journal = {ChemistrySelect},
  year = {2023},
  volume = {8},
  number = {9},
  doi = {10.1002/slct.202204723}
}
Kostenlos starten →